Melsmon Pharmaceutical Co., Ltd.

Melsmon Pharmaceutical Co., Ltd. was established in 1956 in Japan in order to study the properties of human placenta hydrolysate. Longstanding investigations resulted in the development of a unique product, Melsmon, indicated for biorevitalization and mesotherapy. The clinical trials demonstrated that the essence of human placenta, enriched with vitamins and microelements, provides considerable rejuvenating and recovering effect on skin and might be applied as a hair growth stimulator if administered to the scalp.